The Incidence of Hepatocellular Carcinoma after Balloon-Occluded Retrograde Transvenous Obliteration

Table 2

Comparison of patient characteristics between the two groups: group A: patients without history of HCC before B-RTO (N = 40) and the non-BRTO group: patients with viral hepatitis and without history of HCC before treatment excluded BRTO for esophagogastric varices (N = 51).

	Group A (N = 40)	Non-BRTO (N = 51)	value
Age, years	61.5 ± 1.63	60.0 ± 1.44	0.480
Gender
Male	24	30
Female	16	21	0.910
Etiology
HCV	36	41
HBV	4	10	0.207
FIB4 index	9.19 ± 0.89	7.80 ± 0.79	0.244
Child-Pugh score	7.37 ± 0.20	6.98 ± 0.17	0.138
	1.22 ± 0.11	1.18 ± 0.08	0.759
	1.13 ± 0.05	1.21 ± 0.03	0.118

FIB4 index = age (years) × AST [IU/L]/(Plt [109/L] × (ALT [IU/L]) 1/2).
HCV: hepatitis C virus, HBV: hepatitis B virus, AFP: alpha-fetoprotein, and DCP: des-gamma-carboxy prothrombin.